LEXXW Financials
Lexaria Bioscience Corp - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$33.79M
Income Statement Highlights
Most Recent Quarter: 2025-08-31
Revenue
$705,923
Gross Profit
-
Operating Income
-
Net Income
$-11.91M
EPS (Diluted)
$-0.66
Balance Sheet Highlights
Total Assets
$4.18M
Total Liabilities
$1.57M
Shareholders Equity
-
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-10.45M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LEXXW revenue?
LEXXW's most recent quarterly revenue was $705,923. Annual revenue can be calculated by summing the four most recent quarters.
Is LEXXW profitable?
LEXXW reported a loss of $11.91M in the most recent quarter.
What is LEXXW market cap?
LEXXW has a market capitalization of $33.79M, making it a small-cap stock.
Does LEXXW have debt?
View LEXXW's balance sheet for debt information.
What is LEXXW cash flow?
Cash flow data is available in the full financial statements.